It is noteworthy that the current study is one of the very few, also the largest study to evaluate not only the prognostic value, but also the predictive efficacy of deep learning model in a consecutive cohort of HER2-positive breast cancer patients. The gene discussed is ERBB2; the disease is breast carcinoma.